Genetic insight into COVID-19-related liver injury

Liver Int. 2021 Jan;41(1):227-229. doi: 10.1111/liv.14708. Epub 2020 Nov 3.

Authors

Cristiana Bianco¹, Guido Baselli¹, Francesco Malvestiti², Luigi Santoro¹, Serena Pelusi^{1

2}, Maria Manunta¹, Giacomo Grasselli^{2

3}, Alessandra Bandera^{2

4}, Luigia Scudeller⁵, Daniele Prati¹, Luca Valenti^{1

2}

Affiliations

¹ Translational Medicine - Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
² Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
³ Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁴ Infectious diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
⁵ Scientific Direction, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

PMID: 33098230
DOI: 10.1111/liv.14708

No abstract available

Keywords: genetics; hepatitis; infectious disease; liver.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Alanine Transaminase
COVID-19*
Humans
Liver
Liver Diseases*
SARS-CoV-2

Substances

Alanine Transaminase

Grants and funding